# Cerebrolysin for acute ischemic stroke: 90-day trial results

Source: https://pepvault.app/research/cerebrolysin-heiss-2012

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Cerebrolysin](https://pepvault.app/research#cerebrolysin)

Randomized trial · people

# Cerebrolysin: no overall benefit in acute ischemic stroke at 90 days

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this large trial Cerebrolysin did not improve overall stroke recovery, and the possible benefit in severe strokes is a lead to test, not a settled result.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 1070
- **Published:** 2012
- **Journal:** Stroke

## What they tested

The team tested whether Cerebrolysin works and is safe in people with an acute ischemic stroke, a stroke caused by a blocked blood vessel in the brain.

## How the study was done

A double-blind, placebo-controlled randomized trial in 1070 patients in Asia, started within 12 hours of stroke symptoms, comparing 30 mL Cerebrolysin with placebo (a saline drip), each given as a daily intravenous infusion for 10 days on top of 100 mg aspirin daily, with follow-up to 90 days. The main outcome combined three stroke scales: the modified Rankin Scale (disability), the Barthel Index (daily-living ability) and the NIH Stroke Scale (NIHSS, stroke severity).

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

On the main combined outcome, Cerebrolysin and placebo did not differ significantly. In a post hoc look at patients with severe strokes (NIHSS above 12), results leaned toward Cerebrolysin on the NIHSS (OR 1.27, CI lower bound 0.97) and the modified Rankin Scale (OR 1.27, CI lower bound 0.90), though these were trends. In that same severe group, death by 90 days was 20.2% with placebo and 10.5% with Cerebrolysin (hazard ratio 1.9661, CI lower bound 1.0013).

## What it doesn’t show

The main result was neutral, and the hint of benefit in severe strokes comes from a post hoc subgroup analysis, which can't confirm an effect on its own. The researchers said a further trial is needed to check it.

## The paper

Heiss et al. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke. 2012.

- [PubMed (PMID 22282884)](https://pubmed.ncbi.nlm.nih.gov/22282884/)
- [The paper (DOI 10.1161/STROKEAHA.111.628537)](https://doi.org/10.1161/STROKEAHA.111.628537)
- [ClinicalTrials.gov (NCT00868283)](https://clinicaltrials.gov/study/NCT00868283)

## The compound

- [Cerebrolysin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

## With this study

### Cerebrolysin

- [Cerebrolysin: the full reference](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

### Studies

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018)
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015)
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016)
- [All 4 studies](https://pepvault.app/research#cerebrolysin)

### Compared with

- [Semax vs Cerebrolysin](https://pepvault.app/peptides/compare/semax-vs-cerebrolysin)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Cerebrolysin

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018) Meta-analysis · people · 2018
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015) Meta-analysis · people · 2015
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016) Randomized trial · people · 2016
- [Every study on Cerebrolysin](https://pepvault.app/research#cerebrolysin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Cerebrolysin

- [Cerebrolysin: the full reference](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

### Studies

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018)
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015)
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016)
- [All 4 studies](https://pepvault.app/research#cerebrolysin)

### Compared with

- [Semax vs Cerebrolysin](https://pepvault.app/peptides/compare/semax-vs-cerebrolysin)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Cerebrolysin](https://pepvault.app/research#cerebrolysin)

## The library

- [Cerebrolysin](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
